It is a new, experimental procedure, used when there is: Premature ovarian failure (early menopause). Suboptimal response to hormone stimulation (low egg numbers during IVF or ICSI or low AMH). Advanced maternal age. It involves injecting growth factors, a technique similar to that used to extract eggs for IVF. Success of the treatment may be seen by: A return of menstrual periods where they previously had stopped. A reduction in FSH levels and a rise in AMH levels in menopausal women.